(OTCQB: BIXT) (the "Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...

Tens of millions of pounds in investment is being provided by the group of firms which includes AstraZenecaa and Pfizer ...

Abbvie said on Friday it would record a charge of about $3.5 billion related to its experimental schizophrenia drug, ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

GEMMA Collins has revealed that she’s dropped two dress sizes after turning to fat loss injections. The TV favourite, 43, who has previously struggled with her weight, has now teamed up with ...

Share on PinterestThe virus causing cold sores may also be linked to Alzheimer’s risk, a new study suggests. Image credit: ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

"During the early stage, it's possible for people with dementia to live well by taking control of their health and wellness, ...

The new CDC numbers on flu season will come out early next week. There was a delay because of federal offices being closed on ...